Jeffrey W. Albers, Director at Blueprint Medicines Corp (BPMC), sold 22,036 shares at $67.25 ($1.5M) on 2023-11-24, disclosed to the SEC on 2023-11-28.
Scheduled sale ($1.5M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $67.25 | 7,964 | $536K | 35.9% |
| 2 | $67.81 | 7,036 | $477K | 32.0% |
| 3 | $67.81 | 7,036 | $477K | 32.0% |
| Total | $67.61 avg | 22,036 | $1.5M | 100% |
| Filing → |
| KYMR | SELL | 2025-10-14 | $296K | — | Filing → |
| KYMR | SELL | 2025-06-03 | $311K | — | Filing → |
| BPMC | SELL | 2025-05-29 | $572K | — | Filing → |